APEX BIOVENTURES ACQUISITION CORP
Liquidated 2009-06-02- CIK 1368613
- PEX
- IPO 2007-06-08
- $67.4M trust
- 89 filings
- IPO Size
- $69M
- raised at the IPO
- Trust Amount
- $67.4M
- held for shareholders
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2007
- year it listed
Filings, by quarter
89 filings over 13 quarters; violet bars carry a milestone
- 06 Q3: 4 filings
- 06 Q4: 1 filing
- 07 Q1: 0 filings
- 07 Q2: 23 filings
- 07 Q3: 6 filings
- 07 Q4: 2 filings
- 08 Q1: 10 filings
- 08 Q2: 6 filings
- 08 Q3: 1 filing
- 08 Q4: 7 filings
- 09 Q1: 17 filings
- 09 Q2: 11 filings
- 09 Q3: 1 filing
- S-1 filed 06 Q3
- IPO 07 Q2
- Liquidated 09 Q2
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Apex Bioventures Acquisition Corporation is a blank-check company formed to acquire one or more operating businesses in the healthcare industry through a business combination.
Investment Focus
Healthcare
Key Information
As the filings state it
- IPO Date
- 2007-06-08
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2009-06-02
- SPAC Ticker
- PEX
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The management team includes experienced healthcare and life-sciences executives and investors with backgrounds in biotechnology, pharmaceuticals, healthcare consulting, venture capital, and company management.